{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:29:53Z","timestamp":1775100593859,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH094604"],"award-info":[{"award-number":["MH094604"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH081066"],"award-info":[{"award-number":["MH081066"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32MH016434"],"award-info":[{"award-number":["T32MH016434"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00213-020-05758-8","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T08:33:05Z","timestamp":1611909185000},"page":"1111-1120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serotonin 5-HT1B receptor-mediated behavior and binding in mice with the overactive and dysregulated serotonin transporter Ala56 variant"],"prefix":"10.1007","volume":"238","author":[{"given":"Kally C.","family":"O\u2019Reilly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren C.","family":"Shuffrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy D.","family":"Blakely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne E.","family":"Ahmari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6349-1076","authenticated-orcid":false,"given":"Jeremy","family":"Veenstra-VanderWeele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"5758_CR1","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/npp.2011.308","volume":"37","author":"SE Ahmari","year":"2012","unstructured":"Ahmari SE, Risbrough VB, Geyer MA, Simpson HB (2012) Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder. Neuropsychopharmacology 37:1216\u20131223","journal-title":"Neuropsychopharmacology"},{"key":"5758_CR2","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1038\/npp.2015.363","volume":"41","author":"SE Ahmari","year":"2016","unstructured":"Ahmari SE, Risbrough VB, Geyer MA, Simpson HB (2016) Prepulse inhibition deficits in obsessive-compulsive disorder are more pronounced in females. Neuropsychopharmacology 41:2963\u20132964","journal-title":"Neuropsychopharmacology"},{"key":"5758_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neuroscience.2011.01.041","volume":"180","author":"LC Baldan Ramsey","year":"2011","unstructured":"Baldan Ramsey LC, Xu M, Wood N, Pittenger C (2011) Lesions of the dorsomedial striatum disrupt prepulse inhibition. Neuroscience 180:222\u2013228","journal-title":"Neuroscience"},{"key":"5758_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/1362361307075699","volume":"11","author":"S Bejerot","year":"2007","unstructured":"Bejerot S (2007) An autistic dimension: a proposed subtype of obsessive-compulsive disorder. Autism 11:101\u2013110","journal-title":"Autism"},{"key":"5758_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0306-4522(94)90164-3","volume":"58","author":"U Boschert","year":"1994","unstructured":"Boschert U, Amara DA, Segu L, Hen R (1994) The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience 58:167\u2013182","journal-title":"Neuroscience"},{"key":"5758_CR6","doi-asserted-by":"publisher","first-page":"e764","DOI":"10.1038\/tp.2016.30","volume":"6","author":"C Cappi","year":"2016","unstructured":"Cappi C, Brentani H, Lima L, Sanders SJ, Zai G, Diniz BJ, Reis VN, Hounie AG, Conceicao do Rosario M, Mariani D, Requena GL, Puga R, Souza-Duran FL, Shavitt RG, Pauls DL, Miguel EC, Fernandez TV (2016) Whole-exome sequencing in obsessive-compulsive disorder identifies rare mutations in immunological and neurodevelopmental pathways. Transl Psychiatry 6:e764","journal-title":"Transl Psychiatry"},{"key":"5758_CR7","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1073\/pnas.0809449106","volume":"106","author":"AM Carneiro","year":"2009","unstructured":"Carneiro AM, Airey DC, Thompson B, Zhu CB, Lu L, Chesler EJ, Erikson KM, Blakely RD (2009) Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes. Proc Natl Acad Sci U S A 106:2047\u20132052","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5758_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.euroneuro.2010.10.006","volume":"21","author":"N Dawson","year":"2011","unstructured":"Dawson N, Ferrington L, Lesch KP, Kelly PA (2011) Cerebral metabolic responses to 5-HT2A\/C receptor activation in mice with genetically modified serotonin transporter (SERT) expression. Eur Neuropsychopharmacol 21:117\u2013128","journal-title":"Eur Neuropsychopharmacol"},{"key":"5758_CR9","first-page":"139","volume":"39","author":"SC Dulawa","year":"1996","unstructured":"Dulawa SC, Geyer MA (1996) Psychopharmacology of prepulse inhibition in mice. Chin J Phys 39:139\u2013146","journal-title":"Chin J Phys"},{"key":"5758_CR10","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/S0028-3908(00)00030-7","volume":"39","author":"SC Dulawa","year":"2000","unstructured":"Dulawa SC, Geyer MA (2000) Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology 39:2170\u20132179","journal-title":"Neuropharmacology"},{"key":"5758_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s002130050328","volume":"132","author":"SC Dulawa","year":"1997","unstructured":"Dulawa SC, Hen R, Scearce-Levie K, Geyer MA (1997) Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice. Psychopharmacology 132:125\u2013134","journal-title":"Psychopharmacology"},{"key":"5758_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1749-6632.1998.tb10176.x","volume":"861","author":"SC Dulawa","year":"1998","unstructured":"Dulawa SC, Hen R, Scearce-Levie K, Geyer MA (1998) 5-HT1B receptor modulation of prepulse inhibition: recent findings in wild-type and 5-HT1B knockout mice. Ann N Y Acad Sci 861:79\u201384","journal-title":"Ann N Y Acad Sci"},{"key":"5758_CR13","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0893-133X(99)00164-5","volume":"22","author":"SC Dulawa","year":"2000","unstructured":"Dulawa SC, Gross C, Stark KL, Hen R, Geyer MA (2000) Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology 22:650\u2013659","journal-title":"Neuropsychopharmacology"},{"key":"5758_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41525-019-0093-8","volume":"4","author":"P Feliciano","year":"2019","unstructured":"Feliciano P, Zhou X, Astrovskaya I, Turner TN, Wang T, Brueggeman L, Barnard R, Hsieh A, Snyder LG, Muzny DM, Sabo A, Consortium S, Gibbs RA, Eichler EE, O\u2019Roak BJ, Michaelson JJ, Volfovsky N, Shen Y, Chung WK (2019) Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes. NPJ Genom Med 4:19","journal-title":"NPJ Genom Med"},{"key":"5758_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.mp.4001432","volume":"9","author":"PW Frankland","year":"2004","unstructured":"Frankland PW, Wang Y, Rosner B, Shimizu T, Balleine BW, Dykens EM, Ornitz EM, Silva AJ (2004) Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry 9:417\u2013425","journal-title":"Mol Psychiatry"},{"key":"5758_CR16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.euroneuro.2014.02.004","volume":"24","author":"S Gabriele","year":"2014","unstructured":"Gabriele S, Sacco R, Persico AM (2014) Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur Neuropsychopharmacol 24:919\u2013929","journal-title":"Eur Neuropsychopharmacol"},{"key":"5758_CR17","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/0006-3223(91)90193-P","volume":"29","author":"GL Hanna","year":"1991","unstructured":"Hanna GL, Yuwiler A, Cantwell DP (1991) Whole blood serotonin in juvenile obsessive-compulsive disorder. Biol Psychiatry 29:738\u2013744","journal-title":"Biol Psychiatry"},{"key":"5758_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/0165-6147(92)90054-A","volume":"13","author":"R Hen","year":"1992","unstructured":"Hen R (1992) Of mice and flies: commonalities among 5-HT receptors. Trends Pharmacol Sci 13:160\u2013165","journal-title":"Trends Pharmacol Sci"},{"key":"5758_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00213-015-4086-8","volume":"233","author":"EV Ho","year":"2016","unstructured":"Ho EV, Thompson SL, Katzka WR, Sharifi MF, Knowles JA, Dulawa SC (2016) Clinically effective OCD treatment prevents 5-HT1B receptor-induced repetitive behavior and striatal activation. Psychopharmacology 233:57\u201370","journal-title":"Psychopharmacology"},{"key":"5758_CR20","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.biopsych.2005.01.040","volume":"57","author":"K Hoenig","year":"2005","unstructured":"Hoenig K, Hochrein A, Quednow BB, Maier W, Wagner M (2005) Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biol Psychiatry 57:1153\u20131158","journal-title":"Biol Psychiatry"},{"key":"5758_CR21","first-page":"1648","volume-title":"Neuropsychopharmacology: the fifth generation of progress","author":"E Hollander","year":"2002","unstructured":"Hollander E, Pallanti S (2002) Current and experimental therapeutics of OCD. In: Davis K, Charney D, Coyle J, Nemeroff C (eds) Neuropsychopharmacology: the fifth generation of progress. Lippincott Williams & Wilkins, Philadelphia, pp 1648\u20131655"},{"key":"5758_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0893-133X(99)00121-9","volume":"22","author":"E Hollander","year":"2000","unstructured":"Hollander E, Novotny S, Allen A, Aronowitz B, Cartwright C, DeCaria C (2000) The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology 22:163\u2013167","journal-title":"Neuropsychopharmacology"},{"key":"5758_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/hmg\/7.3.571","volume":"7","author":"International Molecular Genetic Study of Autism Consortium","year":"1998","unstructured":"International Molecular Genetic Study of Autism Consortium (1998) A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum Mol Genet 7:571\u2013578","journal-title":"Hum Mol Genet"},{"key":"5758_CR24","doi-asserted-by":"publisher","first-page":"8955","DOI":"10.1523\/JNEUROSCI.5356-05.2006","volume":"26","author":"KA Jennings","year":"2006","unstructured":"Jennings KA, Loder MK, Sheward WJ, Pei Q, Deacon RM, Benson MA, Olverman HJ, Hastie ND, Harmar AJ, Shen S, Sharp T (2006) Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J Neurosci 26:8955\u20138964","journal-title":"J Neurosci"},{"key":"5758_CR25","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.neuropharm.2007.12.001","volume":"54","author":"KA Jennings","year":"2008","unstructured":"Jennings KA, Sheward WJ, Harmar AJ, Sharp T (2008) Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function. Neuropharmacology 54:776\u2013783","journal-title":"Neuropharmacology"},{"key":"5758_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jpsychires.2012.11.018","volume":"47","author":"S Kohl","year":"2013","unstructured":"Kohl S, Heekeren K, Klosterkotter J, Kuhn J (2013) Prepulse inhibition in psychiatric disorders--apart from schizophrenia. J Psychiatr Res 47:445\u2013452","journal-title":"J Psychiatr Res"},{"key":"5758_CR27","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10803-006-0123-0","volume":"36","author":"OT Leyfer","year":"2006","unstructured":"Leyfer OT, Folstein SE, Bacalman S, Davis NO, Dinh E, Morgan J, Tager-Flusberg H, Lainhart JE (2006) Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord 36:849\u2013861","journal-title":"J Autism Dev Disord"},{"key":"5758_CR28","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/brain\/awf150","volume":"125","author":"GM McAlonan","year":"2002","unstructured":"McAlonan GM, Daly E, Kumari V, Critchley HD, van Amelsvoort T, Suckling J, Simmons A, Sigmundsson T, Greenwood K, Russell A, Schmitz N, Happe F, Howlin P, Murphy DG (2002) Brain anatomy and sensorimotor gating in Asperger\u2019s syndrome. Brain 125:1594\u20131606","journal-title":"Brain"},{"key":"5758_CR29","doi-asserted-by":"publisher","first-page":"15742","DOI":"10.1523\/JNEUROSCI.2989-11.2011","volume":"31","author":"E Morelli","year":"2011","unstructured":"Morelli E, Moore H, Rebello TJ, Gray N, Steele K, Esposito E, Gingrich JA, Ansorge MS (2011) Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction. J Neurosci 31:15742\u201315750","journal-title":"J Neurosci"},{"key":"5758_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","volume":"321","author":"CL Muller","year":"2016","unstructured":"Muller CL, Anacker AMJ, Veenstra-VanderWeele J (2016) The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience 321:24\u201341","journal-title":"Neuroscience"},{"key":"5758_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1017\/S146114570400433X","volume":"7","author":"S Novotny","year":"2004","unstructured":"Novotny S, Hollander E, Phillips A, Allen A, Wasserman S, Iyengar R (2004) Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders. Int J Neuropsychopharmacol 7:249\u2013254","journal-title":"Int J Neuropsychopharmacol"},{"key":"5758_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.nlm.2016.07.034","volume":"134 Pt B","author":"KC O\u2019Reilly","year":"2016","unstructured":"O\u2019Reilly KC, Perica MI, Fenton AA (2016) Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult. Neurobiol Learn Mem 134 Pt B:294\u2013303","journal-title":"Neurobiol Learn Mem"},{"key":"5758_CR33","doi-asserted-by":"publisher","first-page":"135027","DOI":"10.1016\/j.neulet.2020.135027","volume":"730","author":"KC O\u2019Reilly","year":"2020","unstructured":"O\u2019Reilly KC, Anacker AMJ, Rogers TD, Forsberg CG, Wang J, Zhang B, Blakely RD, Veenstra-VanderWeele J (2020) A social encounter drives gene expression changes linked to neuronal function, brain development, and related disorders in mice expressing the serotonin transporter Ala56 variant. Neurosci Lett 730:135027","journal-title":"Neurosci Lett"},{"key":"5758_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-8993(85)90856-X","volume":"346","author":"A Pazos","year":"1985","unstructured":"Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205\u2013230","journal-title":"Brain Res"},{"key":"5758_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jad.2016.02.021","volume":"196","author":"C Pittenger","year":"2016","unstructured":"Pittenger C, Adams TG Jr, Gallezot JD, Crowley MJ, Nabulsi N, James R, Gao H, Kichuk SA, Simpson R, Billingslea E, Hannestad J, Bloch M, Mayes L, Bhagwagar Z, Carson RE (2016) OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding. J Affect Disord 196:87\u201396","journal-title":"J Affect Disord"},{"key":"5758_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF02206997","volume":"21","author":"J Piven","year":"1991","unstructured":"Piven J, Tsai GC, Nehme E, Coyle JT, Chase GA, Folstein SE (1991) Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord 21:51\u201359","journal-title":"J Autism Dev Disord"},{"key":"5758_CR37","doi-asserted-by":"publisher","first-page":"11545","DOI":"10.1073\/pnas.0501432102","volume":"102","author":"HC Prasad","year":"2005","unstructured":"Prasad HC, Zhu CB, McCauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC, Hewlett WA, Sutcliffe JS, Blakely RD (2005) Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci U S A 102:11545\u201311550","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5758_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1098\/rstb.2008.0143","volume":"364","author":"HC Prasad","year":"2009","unstructured":"Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD (2009) Enhanced activity of human serotonin transporter variants associated with autism. Philos Trans R Soc Lond Ser B Biol Sci 364:163\u2013173","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"5758_CR39","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1021\/acschemneuro.8b00689","volume":"10","author":"MA Quinlan","year":"2019","unstructured":"Quinlan MA, Krout D, Katamish RM, Robson MJ, Nettesheim C, Gresch PJ, Mash DC, Henry LK, Blakely RD (2019) Human serotonin transporter coding variation establishes conformational bias with functional consequences. ACS Chem Neurosci 10:3249\u20133260","journal-title":"ACS Chem Neurosci"},{"key":"5758_CR40","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1038\/npp.2013.150","volume":"38","author":"CI Rodriguez","year":"2013","unstructured":"Rodriguez CI, Kegeles LS, Levinson A, Feng T, Marcus SM, Vermes D, Flood P, Simpson HB (2013) Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology 38:2475\u20132483","journal-title":"Neuropsychopharmacology"},{"key":"5758_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.neubiorev.2004.08.008","volume":"28","author":"Y Sari","year":"2004","unstructured":"Sari Y (2004) Serotonin1B receptors: from protein to physiological function and behavior. Neurosci Biobehav Rev 28:565\u2013582","journal-title":"Neurosci Biobehav Rev"},{"key":"5758_CR42","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0193-953X(05)70181-7","volume":"23","author":"S Saxena","year":"2000","unstructured":"Saxena S, Rauch SL (2000) Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin N Am 23:563\u2013586","journal-title":"Psychiatr Clin N Am"},{"key":"5758_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.biopsych.2008.09.026","volume":"65","author":"NA Shanahan","year":"2009","unstructured":"Shanahan NA, Holick Pierz KA, Masten VL, Waeber C, Ansorge M, Gingrich JA, Geyer MA, Hen R, Dulawa SC (2009) Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice. Biol Psychiatry 65:401\u2013408","journal-title":"Biol Psychiatry"},{"key":"5758_CR44","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.biopsych.2011.07.032","volume":"70","author":"NA Shanahan","year":"2011","unstructured":"Shanahan NA, Velez LP, Masten VL, Dulawa SC (2011) Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice. Biol Psychiatry 70:1039\u20131048","journal-title":"Biol Psychiatry"},{"key":"5758_CR45","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s41593-019-0429-9","volume":"22","author":"Q Sun","year":"2019","unstructured":"Sun Q, Li X, Ren M, Zhao M, Zhong Q, Ren Y, Luo P, Ni H, Zhang X, Zhang C, Yuan J, Li A, Luo M, Gong H, Luo Q (2019) A whole-brain map of long-range inputs to GABAergic interneurons in the mouse medial prefrontal cortex. Nat Neurosci 22:1357\u20131370","journal-title":"Nat Neurosci"},{"key":"5758_CR46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/432648","volume":"77","author":"JS Sutcliffe","year":"2005","unstructured":"Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L, Li C, Folstein SE, Blakely RD (2005) Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 77:265\u2013279","journal-title":"Am J Hum Genet"},{"key":"5758_CR47","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s002130100799","volume":"156","author":"NR Swerdlow","year":"2001","unstructured":"Swerdlow NR, Geyer MA, Braff DL (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156:194\u2013215","journal-title":"Psychopharmacology"},{"key":"5758_CR48","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00429-014-0935-1","volume":"221","author":"A Szonyi","year":"2016","unstructured":"Szonyi A, Mayer MI, Cserep C, Takacs VT, Watanabe M, Freund TF, Nyiri G (2016) The ascending median raphe projections are mainly glutamatergic in the mouse forebrain. Brain Struct Funct 221:735\u2013751","journal-title":"Brain Struct Funct"},{"key":"5758_CR49","doi-asserted-by":"publisher","first-page":"e0211239","DOI":"10.1371\/journal.pone.0211239","volume":"14","author":"SL Thompson","year":"2019","unstructured":"Thompson SL, Dulawa SC (2019) Dissecting the roles of beta-arrestin2 and GSK-3 signaling in 5-HT1BR-mediated perseverative behavior and prepulse inhibition deficits in mice. PLoS One 14:e0211239","journal-title":"PLoS One"},{"key":"5758_CR50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00213-019-05397-8","volume":"237","author":"SL Thompson","year":"2020","unstructured":"Thompson SL, Welch AC, Iourinets J, Dulawa SC (2020) Ketamine induces immediate and delayed alterations of OCD-like behavior. Psychopharmacology 237:627\u2013638","journal-title":"Psychopharmacology"},{"key":"5758_CR51","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11689-009-9020-0","volume":"1","author":"J Veenstra-Vanderweele","year":"2009","unstructured":"Veenstra-Vanderweele J, Jessen TN, Thompson BJ, Carter M, Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD (2009) Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse. J Neurodev Disord 1:158\u2013171","journal-title":"J Neurodev Disord"},{"key":"5758_CR52","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1073\/pnas.1112345109","volume":"109","author":"J Veenstra-VanderWeele","year":"2012","unstructured":"Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, Shah CR, Cohen J, Mannangatti P, Jessen T, Thompson BJ, Ye R, Kerr TM, Carneiro AM, Crawley JN, Sanders-Bush E, McMahon DG, Ramamoorthy S, Daws LC, Sutcliffe JS, Blakely RD (2012) Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A 109:5469\u20135474","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5758_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/YPG.0b013e3282f08a06","volume":"18","author":"JR Wendland","year":"2008","unstructured":"Wendland JR, DeGuzman TB, McMahon F, Rudnick G, Detera-Wadleigh SD, Murphy DL (2008) SERT Ileu425Val in autism, Asperger syndrome and obsessive-compulsive disorder. Psychiatr Genet 18:31\u201339","journal-title":"Psychiatr Genet"},{"key":"5758_CR54","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1097\/00001756-199804200-00047","volume":"9","author":"D Wirtshafter","year":"1998","unstructured":"Wirtshafter D, Cook DF (1998) Serotonin-1B agonists induce compartmentally organized striatal Fos expression in rats. Neuroreport 9:1217\u20131221","journal-title":"Neuroreport"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05758-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-020-05758-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05758-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T15:05:51Z","timestamp":1667055951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-020-05758-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["5758"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05758-8","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"20 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JV has consulted or served on advisory boards for Novartis, Roche Pharmaceuticals, and SynapDx; has received research funding from Novartis, Roche Pharmaceuticals, Forest, Seaside Therapeutics, Janssen, and SynapDx; and has received an editorial stipend from Springer and Wiley. All other authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}